Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110


Development of a contemporary globally diverse HIV viral panel by the EQAPOL program.

Sanchez AM, DeMarco CT, Hora B, Keinonen S, Chen Y, Brinkley C, Stone M, Tobler L, Keating S, Schito M, Busch MP, Gao F, Denny TN.

J Immunol Methods. 2014 Jul;409:117-30. doi: 10.1016/j.jim.2014.01.004. Epub 2014 Jan 19.


Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials.

Sambor A, Garcia A, Berrong M, Pickeral J, Brown S, Rountree W, Sanchez A, Pollara J, Frahm N, Keinonen S, Kijak GH, Roederer M, Levine G, D'Souza MP, Jaimes M, Koup R, Denny T, Cox J, Ferrari G.

J Immunol Methods. 2014 Jul;409:107-16. doi: 10.1016/j.jim.2014.04.005. Epub 2014 Apr 29.


Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL).

Todd CA, Sanchez AM, Garcia A, Denny TN, Sarzotti-Kelsoe M.

J Immunol Methods. 2014 Jul;409:91-8. doi: 10.1016/j.jim.2013.09.012. Epub 2013 Oct 9. Review.


Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal.

Ducar C, Smith D, Pinzon C, Stirewalt M, Cooper C, McElrath MJ, Hural J; NIAID HIV Vaccine Trials Network.

J Immunol Methods. 2014 Jul;409:9-20. doi: 10.1016/j.jim.2014.03.024. Epub 2014 Apr 4.


The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells.

Sarzotti-Kelsoe M, Needham LK, Rountree W, Bainbridge J, Gray CM, Fiscus SA, Ferrari G, Stevens WS, Stager SL, Binz W, Louzao R, Long KO, Mokgotho P, Moodley N, Mackay M, Kerkau M, McMillion T, Kirchherr J, Soderberg KA, Haynes BF, Denny TN.

J Immunol Methods. 2014 Jul;409:21-30. doi: 10.1016/j.jim.2014.05.013. Epub 2014 Jun 5.


Introduction to a Special Issue of the Journal of Immunological Methods: Building global resource programs to support HIV/AIDS clinical trial studies.

Sanchez AM, Denny TN, O'Gorman M.

J Immunol Methods. 2014 Jul;409:1-5. doi: 10.1016/j.jim.2014.05.016. Epub 2014 Jun 6.


Toward development of a comprehensive external quality assurance program for polyfunctional intracellular cytokine staining assays.

Staats JS, Enzor JH, Sanchez AM, Rountree W, Chan C, Jaimes M, Chan RC, Gaur A, Denny TN, Weinhold KJ.

J Immunol Methods. 2014 Jul;409:44-53. doi: 10.1016/j.jim.2014.05.021. Epub 2014 Jun 23.


Development and implementation of a proficiency testing program for Luminex bead-based cytokine assays.

Lynch HE, Sanchez AM, D'Souza MP, Rountree W, Denny TN, Kalos M, Sempowski GD.

J Immunol Methods. 2014 Jul;409:62-71. doi: 10.1016/j.jim.2014.04.011. Epub 2014 May 4. Review.


Leukopak PBMC sample processing for preparing quality control material to support proficiency testing programs.

Garcia A, Keinonen S, Sanchez AM, Ferrari G, Denny TN, Moody MA.

J Immunol Methods. 2014 Jul;409:99-106. doi: 10.1016/j.jim.2014.05.019. Epub 2014 Jun 10.


Statistical methods for the assessment of EQAPOL proficiency testing: ELISpot, Luminex, and Flow Cytometry.

Rountree W, Vandergrift N, Bainbridge J, Sanchez AM, Denny TN.

J Immunol Methods. 2014 Jul;409:72-81. doi: 10.1016/j.jim.2014.01.007. Epub 2014 Jan 20.


The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay.

Sanchez AM, Rountree W, Berrong M, Garcia A, Schuetz A, Cox J, Frahm N, Manak M, Sarzotti-Kelsoe M, D'Souza MP, Denny T, Ferrari G.

J Immunol Methods. 2014 Jul;409:31-43. doi: 10.1016/j.jim.2014.03.017. Epub 2014 Mar 28.


The Immunology Quality Assessment Proficiency Testing Program for CD3⁺4⁺ and CD3⁺8⁺ lymphocyte subsets: a ten year review via longitudinal mixed effects modeling.

Bainbridge J, Wilkening CL, Rountree W, Louzao R, Wong J, Perza N, Garcia A, Denny TN.

J Immunol Methods. 2014 Jul;409:82-90. doi: 10.1016/j.jim.2014.05.017. Epub 2014 Jun 7.


Setting objective thresholds for rare event detection in flow cytometry.

Richards AJ, Staats J, Enzor J, McKinnon K, Frelinger J, Denny TN, Weinhold KJ, Chan C.

J Immunol Methods. 2014 Jul;409:54-61. doi: 10.1016/j.jim.2014.04.002. Epub 2014 Apr 12.


Pilot studies for development of an HIV subtype panel for surveillance of global diversity.

Manak M, Sina S, Anekella B, Hewlett I, Sanders-Buell E, Ragupathy V, Kim J, Vermeulen M, Stramer SL, Sabino E, Grabarczyk P, Michael N, Peel S, Garrett P, Tovanabutra S, Busch MP, Schito M.

AIDS Res Hum Retroviruses. 2012 Jun;28(6):594-606. doi: 10.1089/AID.2011.0271. Epub 2012 Feb 24.


Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses.

Naarding MA, Fernandez N, Kappes JC, Hayes P, Ahmed T, Icyuz M, Edmonds TG, Bergin P, Anzala O, Hanke T, Clark L, Cox JH, Cormier E, Ochsenbauer C, Gilmour J.

J Immunol Methods. 2014 Jul;409:161-73. doi: 10.1016/j.jim.2013.11.021. Epub 2013 Nov 28.


The role of the reporting framework MIATA within current efforts to advance immune monitoring.

Janetzki S, Britten CM; MIATA Core Team.

J Immunol Methods. 2014 Jul;409:6-8. doi: 10.1016/j.jim.2014.05.003. Epub 2014 May 9. No abstract available.


Development of an HIV-1 Subtype Panel in China: Isolation and Characterization of 30 HIV-1 Primary Strains Circulating in China.

Han J, Liu S, Guo W, Bao Z, Wang X, Li L, Liu Y, Zhuang D, Li H, Jia L, Gui T, Sui H, Li T, Li J.

PLoS One. 2015 May 27;10(5):e0127696. doi: 10.1371/journal.pone.0127696. eCollection 2015.


Genetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International Sites.

Hora B, Keating SM, Chen Y, Sanchez AM, Sabino E, Hunt G, Ledwaba J, Hackett J Jr, Swanson P, Hewlett I, Ragupathy V, Vikram Vemula S, Zeng P, Tee KK, Chow WZ, Ji H, Sandstrom P, Denny TN, Busch MP, Gao F; REDS-III and EQAPOL programs.

PLoS One. 2016 Jun 17;11(6):e0157340. doi: 10.1371/journal.pone.0157340. eCollection 2016.


Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines.

Brown BK, Darden JM, Tovanabutra S, Oblander T, Frost J, Sanders-Buell E, de Souza MS, Birx DL, McCutchan FE, Polonis VR.

J Virol. 2005 May;79(10):6089-101.


Short communication: Biological and genetic characterization of HIV type 1 subtype B and nonsubtype B transmitted viruses: usefulness for vaccine candidate assessment.

Cuevas MT, Fernández-García A, Pinilla M, García-Alvarez V, Thomson M, Delgado E, González-Galeano M, Miralles C, Serrano-Bengoechea E, Ojea de Castro R, López-Alvarez MJ, Lezáun MJ, Sánchez-García AM, Sánchez-Martínez M, Muñoz-Nieto M, Pérez-Alvarez L.

AIDS Res Hum Retroviruses. 2010 Sep;26(9):1019-25. doi: 10.1089/aid.2010.0018.


Supplemental Content

Support Center